MARKET

DOMH

DOMH

DOMINARI HOLDINGS INC
NASDAQ
3.730
-0.170
-4.36%
Closed 16:00 02/01 EST
OPEN
3.850
PREV CLOSE
3.900
HIGH
3.850
LOW
3.680
VOLUME
36.87K
TURNOVER
47.12K
52 WEEK HIGH
10.20
52 WEEK LOW
3.020
MARKET CAP
20.46M
P/E (TTM)
-0.9486
1D
5D
1M
3M
1Y
5Y
Dominari holdings continues to buyback more shares
Seeking Alpha · 01/19 14:45
BRIEF-Dominari Holdings Provides Update On Share Repurchase Program
Reuters · 01/17 14:15
Dominari Holdings buybacks 5,000 shares of common stock
Seeking Alpha · 01/06 14:36
AIkido Pharma Changes Name to Dominari Holdings
AIkido Pharma Changes Name to Dominari Holdings
MT Newswires · 12/22/2022 11:25
$5 Million Bet On SoFi Technologies? Check Out These 5 Penny Stocks Insiders Are Buying
Benzinga · 12/14/2022 12:06
BRIEF-Aikido Pharma Announces Successful Initial Public Offering Of Asp Isotopes
Reuters · 11/28/2022 14:03
AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes
AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today announced the successful initial public offering ("IPO") of ASP Isotopes ("ASPI"). ASPI priced its initial public offering of 1,250,000 shares of its common stock at a public offering pric...
PR Newswire · 11/28/2022 14:00
HC Wainwright & Co. Maintains Buy on AIkido Pharma, Lowers Price Target to $16
Benzinga · 11/11/2022 15:02
More
About DOMH
Dominari Holdings Inc., formerly AIkido Pharma Inc., is a biotechnology company. The Company has a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The Company’s pipeline consists of patented technology from universities and researchers. The Company advances its therapeutic drug pipeline through a collaboration with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It is also developing a broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Its pancreatic drug candidate, DHA-dFdC, is a chemotherapy treatment for advanced pancreatic cancer.

Webull offers kinds of Dominari Holdings Inc stock information, including NASDAQ:DOMH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DOMH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DOMH stock methods without spending real money on the virtual paper trading platform.